Barbara Musial

Senior Scientist, Oncology Safety AstraZeneca

Seminars

Monday 23rd February 2026
Advancing Safety Assessment of ADCs: Assessing Opportunities & Challenges in In Vitro Model Applications
10:00 am
  • Overviewing ADC toxicities and general strategy at the discovery toxicology stage
  • Exploring examples of applications of advanced in vitro models to complement ADC safety analysis alongside in vivo tools
  • Understanding key gaps and challenges to overcome for in vitro ADC safety assessments 
Barbara Musial Senior Scientist, Oncology Safety AstraZeneca